AbCellera IPO Presentation Deck

IMPROVE DEVELOPMENT OF BISPECIFICS WITH CLINICALLY-VALIDATED PROTEIN Diverse panels. ENGINEERING TECHNOLOGY. Develop bispecifics with native IgG-like format. Optimized discovery yields large and diverse panels • Full IgG format with other additional engineering options SOURCE SEARCH FIND ANALYZE ENGINEER • Predictable development from native antibody format I Stable + manufacturable. Standardized mAb protocols Efficient Proven platform. 0 0 Technology validated in the clinic AbCellera 3

View entire presentation